Association of Kawasaki Disease Shock Syndrome with Giant Coronary Artery Dilatation – Presentation of Two Cases and A Literature Review

Ramush Bejiqi; Hana Bejiqi; Ragip Retkoceri; Arlinda Maloku; Afderdita Mustafa; Rinor R. Bejiqi

doi:10.3889/oamjms.2022.10327

Authors

Ramush Bejiqi Texas Health Science Center, University of Texas, San Antonio, Texas, USA; University of Gjakova “Fehmi Agani”, Medical School, Gjakova, Kosovo; University Clinical Center of Kosovo, Prishtina, Kosovo
Hana Bejiqi Univeristy of Business and Technology, Prishtina, Kosovo
Ragip Retkoceri University Clinical Center of Kosovo, Prishtina, Kosovo
Arlinda Maloku University Clinical Center of Kosovo, Prishtina, Kosovo
Afderdita Mustafa University Clinical Center of Kosovo, Prishtina, Kosovo https://orcid.org/0000-0002-1616-8911
Rinor R. Bejiqi University Clinical Center of Kosovo, Prishtina, Kosovo

DOI:

https://doi.org/10.3889/oamjms.2022.10327

Keywords:

Kawasaki disease, Kawasaki disease shock syndrome, Coronary artery aneurysm, Intravenous immunoglobulin

Abstract

Introduction Kawasaki disease is an acute, self-limited vasculitis of childhood characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in approximately 15 to 25% of untreated children with the disease and may lead to myocardial infarction, sudden death, or ischemic heart disease. Despite an overlap of clinical features with toxic shock syndrome, children with Kawasaki disease generally do not develop chock.

Cases Here we report two old children who presented with a toxic shock-like illness, and were diagnosed with Kawasaki disease when coronary artery abnormalities were found on transthoracic echocardiography, recently reported as a “Kawasaki disease shock syndrome”. Relevant articles about KD and shock were collected and demographic data, clinical presentation, laboratory variables, echocardiogram findings, treatment and special features were analyzed when available.

Conclusion Pediatrics cardiologist should be aware of this potentially severe form of manifestation of the Kawasaki disease.

Key words Kawasaki disease, Kawasaki disease shock syndrome, coronary artery aneurysm, intravenous immunoglobulin,

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Booy R, et al. Kawasaki disease: An evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child. 2002;86(4):286-90. https://doi.org/10.1136/adc.86.4.286 PMid:11919108

Rowley AH, Shulman ST. Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther. 2010;8(2):197-203. https://doi.org/10.1586/eri.09.109 PMid:20109049

Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: Myocardial depression in sepsis and septic shock. Crit Care. 2002;6(6):500-8. https://doi.org/10.1186/cc1822 PMid:12493071

Kanegaye JT, Wilder MS, Molkara D, Frazer JR, Pancheri J, Tremoulet AH, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009;123(5):e783-9. https://doi.org/10.1542/peds.2008-1871 PMid:19403470

Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004;364(9433):533-44. https://doi.org/10.1016/S0140-6736(04)16814-1 PMid:15302199

Wood LE, Tulloh RM. Kawasaki disease in children. Heart. 2009;95(10):787-92. https://doi.org/10.1136/hrt.2008.143669 PMid:18697808

McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, et al. Coronary artery involvement in children with Kawasaki disease: Risk factors from analysis of serial normalized measurements. Circulation. 2007;116(2):174-9. https://doi.org/10.1161/CIRCULATIONAHA.107.690875 PMid:17576863

Rozo JC, Jefferies JL, Eidem BW, Cook PJ. Kawasaki disease in the adult: A case report and review of the literature. Tex Heart Inst J. 2004;31(2):160-4. PMid:15212128

Harnden A, Takahashi M, Burgner D. Kawasaki disease. BMJ. 2009;338:b1514. https://doi.org/10.1136/bmj.b1514 PMid:19416993

Deane Y, James R, Darshan K, David B. Tex Heart Inst J. 2004;31:160-4.

Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, et al. Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: A single-institution experience. Circulation. 2011;123(17):1836-42. https://doi.org/10.1161/CIRCULATIONAHA.110.978213 PMid:21502578

Newbuger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burnms JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association. Circulation. 2004;110(17):2747-71. https://doi.org/10.1161/01.CIR.0000145143.19711.78 PMid:15505111

Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379-85. https://doi.org/10.1161/01.cir.94.6.1379 PMid:8822996

Richardson KL, Jain A, Evans J, Uzun O. Giant coronary artery aneurysm as a feature of coronavirus-related inflammatory syndrome. BMJ Case Rep. 2021;14(7):e238740. https://doi.org/10.1136/bcr-2020-238740 PMid:34210694

Xing Y, Wang H, Yu X, Chen R, Hou Y. Assessment of coronary artery lesions in children with Kawasaki disease: Evaluation of MSCT in comparison with 2-D echocardiography. Pediatr Radiol. 2009;39(11):1209-15. https://doi.org/10.1007/s00247-009-1364-9 PMid:19669746